相关实验视频

Updated: Jun 25, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

在患有初级和二级血管肉瘤的患者中, Sarculator 和 MSKCC 的风险分层

Yonca Steubing¹, Nilofar Ahmadi¹, Flemming Puscz¹

¹Department of Plastic Surgery, Hand Surgery, Burn Center, and Sarcoma Center, BG University Hospital Bergmannsheil Bochum, 44789 Bochum, Germany.

Life (Basel, Switzerland)

|May 25, 2024

概括

Sarculator nomogram 显示了预测血管肉瘤预后的潜力,在一个小患者队列中表现优于MSKCC得分. 这有助于为罕见的肉瘤做出治疗决定.

科学领域:

在瘤学瘤学.
手术病理学手术病理学
生物统计学生物统计学

背景情况:

风险预测得分,如Sarculator和纪念斯隆·凯特林癌症中心 (MSKCC) 的nomograms用于瘤.
这些评分在罕见的亚型 (如血管瘤) 中具有有限的验证,并且没有先前区分初级类型和二级类型.

研究的目的:

评估Sarculator在血管肉瘤患者的预后差异化能力.
为了比较Sarculator的预测准确性与实际的临床结果和MSKCC nomograms.

主要方法:

对31名软组织血管肉瘤患者 (2001-2023) 的回顾性分析.
实际5年生存率与Sarculator预测的生存率的比较.
评估MSKCC的4年,8年和12年的死亡率预测.
利用哈雷尔的c指数进行预测有效性分析.

主要成果:

萨尔库拉托显示出0.726的一致性指数,与预测的5年生存率 (25.97%) 和实际生存率 (22.57%) 紧密对齐.
在这个血管肉瘤队列中,MSKCC的诺姆图显示出有限的预测准确性 (一致性指数<0.7).
与MSKCC相比,Sarculator在血管肉瘤患者的预测性能更好.

结论:

诺米图对于评估血管肉瘤等罕见癌症的预后非常有价值.
Sarculator 在改善血管瘤管理中的临床决策和患者咨询方面表现有前途.
需要在更大的队列中进一步验证以证实这些发现.

关键词:

这是一个 Sarculator.血管瘤是一种血管瘤.辐射疗法辐射疗法软组织肉瘤软组织肉瘤

更多相关视频

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...